Every intervention Outliyr has scored for bone and joint health, ranked by its BioHarmony score for this use case rather than its overall rating. The number beside each name is how well that one thing works for bone and joint health; the tier beside it is what it is worth once safety, cost and effort are counted across everything else.
52 of 111 evaluated interventions score 3.0+ out of 10 for bone and joint health · 14 comparisons
Knapen 2013 anchors the most relevant signal. Vitamin D3 + K2 fits bone joint when deficiency, bone risk, immune seasonality, or fat-soluble nutrient gaps are present. The score stays bounded because benefits…
FDA-cleared nonunion healing 73-89% and OA pain evidence support PEMF's strongest use case. The corrected knee OA citation is Bagnato 2016, not the bad v0 PMID; Tong 2022 pooled 11 OA RCTs…
Whole-Body Vibration appears to support bone health primarily in populations with low baseline density, where low-frequency, low-magnitude protocols have produced small increases in lumbar spine and femoral neck BMD. The evidence tier…
The existing rationale points to this narrower claim: this verified source found lower CTX bone-resorption markers at 24 weeks in postmenopausal women using 6 g/day AKG plus calcium. Fracture reduction. That does…
Fan 2024 found knee osteoarthritis pain reduction across low-level laser therapy trials. The strongest target is joint pain and local inflammation, not bone density. Red Light Therapy may help someone move enough…
De Baaij 2015 anchors the most relevant signal. Magnesium fits bone joint when low intake, stress load, mineral loss, or a form-specific target makes deficiency correction plausible. The score stays bounded because…
Soh 2024 anchors the most relevant signal. Glycine fits bone joint because glycine participates in sleep signaling, glutathione, collagen, methylation, and nervous-system balance, depending on the endpoint. The score stays bounded because…
Lincoff 2023 reports TRAVERSE cardiovascular outcomes trial in 5,246 hypogonadal men with cardiovascular risk; major cardiovascular events non-inferior, with monitoring-relevant safety signals. Cruickshank 2024 points in the same direction, but route, dose,…
Osteoarthritis is curcumin's single best-supported use. A 2022 meta-analysis by Feng and colleagues in BMC Complementary Medicine and Therapies found curcuminoids reduced WOMAC total scores (mean difference around 7 points) and were…
Hagiyama 2024 reports 12 RCTs; 622 patients; low-certainty improvement in patient-reported outcomes and very-low-certainty strength signal after lower-limb surgeries. Wittholz 2024 points in the same direction, but route, dose, baseline status, and…
Pingali 2022 anchors the most relevant signal. Shilajit fits bone joint when purified resin is matched to hormones, sperm parameters, strength fatigue, bone markers, or energy tracking. The score stays bounded because…
Bone rationale is strong preclinically, but Farr 2024 found D+Q did not improve the primary bone resorption endpoint overall. The score stays bounded because Senolytics evidence for bone joint can depend on…
The evidence points to a plausible use case without proving a universal response. Seidenberg AB, An YH 2004 is the best anchor here because it reports review of COX-2 inhibitor concerns in…
Refractory osteomyelitis, osteoradionecrosis, and avascular necrosis are recognized indications per UHMS 2025. This makes bone-joint one of the better medical-adjacent slugs for HBOT scoring. Score higher because the framing is clinician-supervised disease…
Bone-joint use is mostly a community and mechanism extrapolation. Tbeta4 supports cell migration and inflammatory resolution, but no human joint, tendon, or ligament RCT exists for TB-500. Wang 2024 strengthens inflammation-resolution biology…
Strongest non-skin evidence. Schulze 2024 reported less lower-extremity joint discomfort with 5 g/day specific peptides, Koenig 2018 supports bone markers, and UC-II evidence supports joint-specific use. That makes Collagen Peptides more defensible…
Mechanical loading is the right stimulus, and a 5-year weighted-vest plus jumping program preserved hip bone density in postmenopausal women while controls lost significantly (Snow 2000), but that trial was tiny at…
The evidence points to a plausible use case without proving a universal response. Abuknesha et al. 2025 is the best anchor here because it reports 34 randomized trials, 114,326 participants and atrial…
Kreider 2017 reports Foundational 87-citation position stand; safe up to 30 g/day for 5 years. Lanhers 2015 points in the same direction, but route, dose, baseline status, and outcome tracking decide whether…
Vasireddi 2025 anchors the most relevant signal. BPC-157 fits bone joint when the target is tissue repair, vascular recruitment, or inflammation control, but the case still rests mostly on preclinical models. The…
The limitation is real: 8 of 10 knee trials combined HA with glucosamine or chondroitin, so the isolated oral-HA effect is hard to size. Mild, adjunctive symptom relief is the defensible claim,…
Tzang 2024 reports 25 RCTs and 1024 participants; lower SBP, DBP, fasting blood glucose, and triglycerides; no significant adverse-effect excess. Tzang 2024 points in the same direction, but route, dose, baseline status,…
Wang 2023 reviewed BFR effects on bone metabolism, but bone outcomes remain less mature than muscle outcomes. The score stays bounded because Blood-Flow Restriction Training evidence for bone joint can depend on…
Lang 2024 is the cleanest verified anchor for this report. The existing rationale points to this narrower claim: The bone and joint score depends heavily on modality. Cycling and swimming are joint-friendly…
Pooled studies in Hussain 2018 reported symptom relief in rheumatic and arthritic disease, and heat is a familiar way to ease morning stiffness and improve the comfort of movement in stiff joints.…
PEARL suggested small bone or pain signals in subgroups, but primary benefit is not established and wound-healing concerns matter.
Vitamin C is required for the collagen matrix that underlies both bone and cartilage, and deficiency causes bone pain, impaired bone formation, and joint hemorrhage. Observational data link higher vitamin C intake…
Guo 2025 associated metformin with lower knee-arthroplasty incidence and lower knee-pain scores in knee osteoarthritis studies, but the authors cautioned that RCT evidence is sparse. This is exploratory, not a primary metformin…
Bone support is inferred from androgen biology and male-osteoporosis reviews, not dedicated human bone-outcome trials. This is not a joint-pain intervention.
Running sprints add high-rate ground-reaction loading that can support bone, but they also raise tendon and joint injury risk; cycle and rower SIT add little skeletal loading.
Bone-joint support is hypothesis-generating, not a primary indication. Thaung Zaw 2020 included postmenopausal women and provides the adjacent vascular/cognitive population context, but resveratrol lacks a dedicated, replicated osteoporosis or osteoarthritis RCT program.…
Weight loss reduces mechanical knee load, and Lilly's TRIUMPH-4 topline reported WOMAC pain improvements in obesity with knee osteoarthritis. Full peer-reviewed data are still pending, so the v0.x score remains held.
Bone and joint is one of the better-supported uses, though the proof is thinner than the bladder data. A placebo-controlled knee pilot of 114 people found that into-muscle pentosan improved stiffness and…
Farr 2024 phase 2 intermittent D plus Q in 60 postmenopausal women was null on the primary bone turnover endpoint overall. An exploratory high p16 tertile showed P1NP up 34 percent, CTx…
Treadmill and uphill running add impact and loading, but the protocol is not a bone-density plan. Bike-based 4x4 has little direct skeletal loading.
Anti-inflammatory mechanism and some isoflavone bone-density signals exist, but direct joint-outcome evidence for the dietary class is sparse.
Anti-inflammatory mechanism may support joint comfort, but direct joint-specific human RCT evidence remains sparse.
Bone-joint remains speculative relative to skin. GHK-Cu supports collagen and tissue repair biology, and Pickart reviews mention bone repair in preclinical contexts, but clinical osteoarthritis, fracture, or joint-pain trials are not established.…
WB-EMS creates muscular loading with lower external joint load, which helps users who cannot tolerate heavy lifting. Direct bone-density evidence is weaker than conventional resistance training, so this is supportive but not…
Bone-joint support is anti-inflammatory and trial-limited. V0 preserved an osteoarthritis-like KSM-66 signal, but the audit did not re-verify all joint-specific details. Score remains moderate because the mechanism fits but the evidence is…
Two osteoarthritis trials used seaweed-blend or fucoidan products with mixed symptom benefit and no consistent marker change.
Bone concerns concentrate in pediatric classical keto and long-term strict use. Clinical epilepsy protocols monitor calcium, vitamin D, growth, and bone density because risk is real. Adult short-term keto usually does not…
Ming 2016 showed MOTS-c suppressed ovariectomy-induced bone loss through AMPK activation in mice, supporting a preclinical bone signal. No human osteoporosis, joint, or fracture trial exists.
Mechanical joint relief is real in obesity, but rapid weight loss can reduce bone density and lean-mass support if poorly managed.
GH/IGF-1 signaling supports bone remodeling, but tesamorelin trials did not establish DEXA bone-density improvement or joint-specific benefit. Arthralgia is also a known tolerability issue.
Bone support rests on one animal study: Polak 2025 found pine pollen at 150 mg/kg limited cortical and trabecular bone loss in orchidectomized rats. Promising but single-study and animal-only; no human bone…
Magnesium supports bone mineral physiology and potassium may reduce urinary calcium loss, but the evidence is indirect.
No meaningful human bone or joint outcome evidence; anti-inflammatory mechanism only.
Joint load may improve with weight loss, but v0.x bone-loss and fracture concerns remain part of the downside rationale; no audit-verified protective bone trial was supplied.
Calcium and magnesium contribute to bone biology generally, but no bone or joint endpoint trial used marine plasma.
Exercise benefits bone and joints through mechanical loading, but SLU-PP-332 does not replicate loading. No bone-density, cartilage, arthritis, or joint-pain data exists for the compound, so this remains mostly theoretical.
No clinical trial has tested C60 against joint pain, cartilage, osteoarthritis, fracture healing, or bone-density endpoints. Anecdotal joint reports are scattered and selection-biased. The antioxidant rationale is too indirect to compete with…
Nothing matches those filters.
Monthly out-of-pocket cost at the most accessible legitimate channel, at the dose the score was given for. 23 of 52 are not priced yet; those cells are left blank rather than guessed.
| Intervention | Monthly cost | At dose | How you get it |
|---|---|---|---|
| Vitamin D3 + K2 | Not priced yet | ||
| PEMF (Pulsed Electromagnetic Field Therapy) | $3–$117 | 20-30 min mat session | Over the counter |
| Whole-Body Vibration | $50–$100 | 30 Hz, roughly 0.3g, 10-20 min standing | Over the counter |
| Ca-AKG (Calcium Alpha-Ketoglutarate) | $15–$30 | 1 g/day generic Ca-AKG oral | Over the counter |
| Red Light Therapy | $17–$43 | 10-20 min at 6-12 inches, full chest/face/back rotation | Over the counter |
| Magnesium | $10–$20 | 200-400 mg glycinate elemental | Over the counter |
| Glycine | $2–$3 | 3 g oral glycine | Over the counter |
| TRT (Testosterone Replacement Therapy) | $50–$300 | Clinician-selected formulation at the lowest dose likely to restore physiologic testosterone | Prescription |
| Curcumin | $15–$40 | 500 mg curcuminoids | Over the counter |
| Essential Amino Acids | Not priced yet | ||
| Shilajit | $25–$50 | 500 mg purified shilajit | Over the counter |
| Senolytics | Not priced yet | ||
| Celebrex (Celecoxib) | Not priced yet | ||
| Hyperbaric Oxygen Therapy | $3,000–$6,000 | 2.0 ATA for 90 minutes with air breaks | In clinic |
| TB-500 (Thymosin Beta-4 Fragment) | Not priced yet | ||
| Collagen Peptides | $8–$40 | 2.5-10 g hydrolyzed collagen peptides | Over the counter |
| Rucking (Weighted Walking) | Not priced yet | ||
| Omega-3 | $20–$40 | 1-2 g/day combined EPA+DHA | Over the counter |
| Creatine Monohydrate | Not priced yet | ||
| BPC-157 | $40–$80 | 250 to 500 mcg SC 1 to 2x/day near injury site | Grey market |
| Hyaluronic Acid | Not priced yet | ||
| Taurine | $3–$10 | 1-3 g, 30-60 minutes before sleep | Over the counter |
| Blood-Flow Restriction Training | Not priced yet | ||
| Zone 2 Cardio | Not priced yet | Over the counter | |
| Traditional Sauna (Finnish Dry-Heat) | $50 | 15 to 20 minutes at 80 to 100 C | Over the counter |
| Rapamycin | $15–$50 | 3 mg | Prescription |
| Vitamin C (Ascorbic Acid) | Not priced yet | ||
| Metformin | $4–$30 | 500 mg with dinner for 1 week, then 500 mg twice daily for 1 week, then increase by 500 mg/week toward 1000 mg twice daily as tolerated | Prescription |
| Tongkat Ali | $20–$40 | 200 mg/day Physta standardized extract | Over the counter |
| Sprinting (Sprint Interval Training) | Not priced yet | ||
| Resveratrol | Not priced yet | ||
| Retatrutide | $130–$960 | 2 mg, then 4 mg, then 8 mg or 12 mg weekly depending on protocol and tolerability | Research use only |
| Pentosan Polysulfate (Elmiron) | Not priced yet | ||
| Quercetin | $20–$50 | 200 mg/day | Over the counter |
| Norwegian 4×4 | Not priced yet | Over the counter | |
| Polyphenols (Dietary) | Not priced yet | ||
| Astaxanthin | Not priced yet | ||
| GHK-Cu | $30–$100 | 0.5-3% topical serum or cream | Over the counter |
| Full-Body EMS | Not priced yet | ||
| Ashwagandha | $15–$30 | 300 mg KSM-66 with breakfast and 300 mg with dinner | Over the counter |
| Fucoidan (Brown Seaweed Polysaccharide) | Not priced yet | ||
| Ketogenic Diet | $100 | Standard keto, 40-50 g total carbohydrate/day | Over the counter |
| MOTS-c | $100–$200 | 5-10 mg SC | Research use only |
| Semaglutide | $199–$349 | 0.25 mg weeks 1 to 4, 0.5 mg weeks 5 to 8, 1.0 mg weeks 9 to 12, 1.7 mg weeks 13 to 16, 2.4 mg week 17 onward | Prescription |
| Tesamorelin | $250–$500 | 2 mg subcutaneous daily in the evening | Prescription |
| Pine Pollen | $20–$45 | 5 to 10 g powder per day | Over the counter |
| Electrolytes | Not priced yet | ||
| Ergothioneine | Not priced yet | ||
| Tirzepatide | $299–$449 | 2.5 to 5 to 7.5 to 10 to 12.5 to 15 mg | Prescription |
| Quinton Marine Plasma (Seawater Minerals) | Not priced yet | ||
| SLU-PP-332 | $30–$80 | 3-5 mg/day oral | Research use only |
| C60 (Buckminsterfullerene) | Not priced yet |
Head-to-head reports and category rankings that name a winner on this use case.
This page ranks by hormonal fit, not overall BioHarmony score. TRT leads at 9.0–9.5/10. Phosphatidylserine sits fifth at 5.5–6.0/10 despite the second highest overall score here, 7.0–7.5/10. That…
Neither, if fat loss is the goal. Both score 2.0–2.5/10 on body composition, which is the row a vendor sells them on. AOD-9604 scores 3.0–3.5/10 overall and its…
These two get sold as the same thing, a scoop for gut and skin, and they share almost no mechanism. Colostrum is a gut and immune product: gut…
Different jobs, same shelf. Quercetin scores 6.5–7.0/10 and curcumin 5.5–6.0/10, and that gap is the liver-safety signal rather than a difference in effect. Curcumin wins joints, inflammatory markers,…
On weight loss they tie, and neither is a drug you can legitimately buy. Both score 7.5/10 for body composition, and both are investigational Lilly molecules with phase…
Magnesium glycinate is magnesium bound to glycine, so if you take it you already take both. That kills the question for sleep. The real decision: magnesium scores higher…
Buy the panel. Red light therapy scores 7.5–8.0/10 against HBOT's 5.5–6.0/10, costs $17 to $43 a month against $3,000 to $6,000, and does not lose a single use…
Kisspeptin-10 scores 6.0–6.5/10 and TRT 5.5–6.0/10, and TRT still wins 13 of the 15 use cases both reports score. The higher number reflects dependency and reversibility, not effect.…
Red light therapy scores 7.5–8.0/10 and PEMF 7.5–8.0/10, so the panel is the better first buy for most people. PEMF wins on bone and joint pain, where a…
Start on sermorelin. Ipamorelin scores higher overall, yet sermorelin wins thirteen of the sixteen shared use cases and it is the one an anti-aging clinic actually prescribes. Ipamorelin…
Shilajit scores 7.0–7.5/10 and ashwagandha 6.5–7.0/10, but that gap is the least useful number here. These two do different jobs. Shilajit is the mineral and androgen play: male…
Start tirzepatide. It scores 6.0–6.5/10 against retatrutide's 5.5–6.0/10, and the gap is mostly availability and evidence maturity rather than weaker biology. Retatrutide is not approved anywhere, cannot legally…
Vitamin D3 + K2, at 8.0–8.5 out of 10 for bone and joint health. Knapen 2013 anchors the most relevant signal.
Of the top-scoring options, Glycine is the least expensive at about $2 a month, scoring 7.0–7.5 out of 10 for bone and joint health.
C60 (Buckminsterfullerene) scores 3.0–3.5 out of 10 for bone and joint health but only 3.0–3.5 overall, landing in the caution tier once safety, side effects, cost and effort are counted.
52 of the 111 interventions evaluated for bone and joint health score 3.0 out of 10 or better, which is the cut-off for appearing on this page.
